Cargando…

Are T-LGL Leukemia and NK-Chronic Lymphoproliferative Disorder Really Two Distinct Diseases?

Mature Large Granular lymphocytes (LGL) disorders include a spectrum of conditions, ranging from polyclonal to clonal indolent and/or overt leukemic LGL proliferations. Most cases are represented by clonal expansions of TCRα/β+ LGL displaying a CD8+ phenotype with expression of cytotoxic T-cell anti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zambello, Renato, Teramo, Antonella, Gattazzo, Cristina, Semenzato, Gianpietro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	University of Salerno 2014
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4000458/ https://www.ncbi.nlm.nih.gov/pubmed/24778993

Ejemplares similares

Activating KIRs in Chronic Lymphoproliferative Disorder of NK Cells: Protection from Viruses and Disease Induction?
por: Zambello, Renato, et al.
Publicado: (2014)

STAT3 mutation impacts biological and clinical features of T-LGL leukemia
por: Teramo, Antonella, et al.
Publicado: (2017)

LGL Clonal Expansion and Unexplained Cytopenia: Two Clues Don’t Make an Evidence
por: Calabretto, Giulia, et al.
Publicado: (2022)

Lack of Viral Load Within Chronic Lymphoproliferative Disorder of Natural Killer Cells: What Is Outside the Leukemic Clone?
por: Giussani, Edoardo, et al.
Publicado: (2021)

A high definition picture of somatic mutations in chronic lymphoproliferative disorder of natural killer cells
por: Gasparini, Vanessa Rebecca, et al.
Publicado: (2020)

Insights Into Genetic Landscape of Large Granular Lymphocyte Leukemia
por: Teramo, Antonella, et al.
Publicado: (2020)

Neutropenia and Large Granular Lymphocyte Leukemia: From Pathogenesis to Therapeutic Options
por: Calabretto, Giulia, et al.
Publicado: (2021)

HS1, a Lyn Kinase Substrate, Is Abnormally Expressed in B-Chronic Lymphocytic Leukemia and Correlates with Response to Fludarabine-Based Regimen
por: Frezzato, Federica, et al.
Publicado: (2012)

Dominant cytotoxic NK cell subset within CLPD-NK patients identifies a more aggressive NK cell proliferation
por: Barilà, Gregorio, et al.
Publicado: (2018)

Defining TCRγδ lymphoproliferative disorders by combined immunophenotypic and molecular evaluation
por: Teramo, Antonella, et al.
Publicado: (2022)

Cyclophosphamide as a first-line therapy in LGL leukemia
por: Moignet, A, et al.
Publicado: (2014)

NK cells and CD38: Implication for (Immuno)Therapy in Plasma Cell Dyscrasias
por: Zambello, Renato, et al.
Publicado: (2020)

Identification of a miR-146b-Fas ligand axis in the development of neutropenia in T large granular lymphocyte leukemia
por: Mariotti, Barbara, et al.
Publicado: (2020)

STAT3 and STAT5B Mutations in T/NK-Cell Chronic Lymphoproliferative Disorders of Large Granular Lymphocytes (LGL): Association with Disease Features
por: Muñoz-García, Noemí, et al.
Publicado: (2020)

Emergence of a STAT3 mutated NK clone in LGL leukemia
por: Yan, Yiyi, et al.
Publicado: (2014)

Toward a Better Classification System for NK-LGL Disorders
por: Drillet, Gaëlle, et al.
Publicado: (2022)

Cross-talk between chronic lymphocytic leukemia (CLL) tumor B cells and mesenchymal stromal cells (MSCs): implications for neoplastic cell survival
por: Trimarco, Valentina, et al.
Publicado: (2015)

A Pyrazolo[3,4-d]pyrimidine compound inhibits Fyn phosphorylation and induces apoptosis in natural killer cell leukemia
por: Laurenzana, Ilaria, et al.
Publicado: (2016)

A case of LGL leukemia with paucity of erythropoiesis
por: Razavi, Habib M.
Publicado: (2020)

A guilt-by-association mutation network in LGL leukemia
por: Andersson, Emma I., et al.
Publicado: (2017)

Identification of novel STAT5B mutations and characterization of TCRβ signatures in CD4+ T-cell large granular lymphocyte leukemia
por: Bhattacharya, Dipabarna, et al.
Publicado: (2022)

Actionable Strategies to Target Multiple Myeloma Plasma Cell Resistance/Resilience to Stress: Insights From “Omics” Research
por: Manni, Sabrina, et al.
Publicado: (2020)

PB2086: CHRONIC LYMPHOPROLIFERATIVE DISORDER OF NK CELLS WITH LIVER INFILTRATION
por: Otasevic, V., et al.
Publicado: (2022)

Retrovirus insertion site analysis of LGL leukemia patient genomes
por: Li, Weiling, et al.
Publicado: (2019)

Epstein–Barr virus-positive T/NK-cell lymphoproliferative disorders
por: Cai, Qingqing, et al.
Publicado: (2015)

Genetic landscape of T- and NK-cell post-transplant lymphoproliferative disorders
por: Margolskee, Elizabeth, et al.
Publicado: (2016)

Cellular Origins and Pathogenesis of Gastrointestinal NK- and T-Cell Lymphoproliferative Disorders
por: Hue, Susan Swee-Shan, et al.
Publicado: (2022)

Phenotypic profile of expanded NK cells in chronic lymphoproliferative disorders: a surrogate marker for NK-cell clonality
por: Bárcena, Paloma, et al.
Publicado: (2015)

STAT5b in LGL leukemia – a novel therapeutic target?
por: Rajala, Hanna L. M., et al.
Publicado: (2013)

Transcriptomic Abnormalities in Epstein Barr Virus Associated T/NK Lymphoproliferative Disorders
por: de Mel, Sanjay, et al.
Publicado: (2019)

New concepts in EBV-associated B, T, and NK cell lymphoproliferative disorders
por: Quintanilla-Martinez, Leticia, et al.
Publicado: (2022)

Identification of the true hyperdiploid multiple myeloma subset by combining conventional karyotyping and FISH analysis
por: Barilà, Gregorio, et al.
Publicado: (2020)

Cyclophosphamide induces durable molecular and clinical responses in patients with relapsed T-LGL leukemia
por: Braunstein, Zachary, et al.
Publicado: (2022)

Anticipation in Families with Chronic Lymphocytic Leukemia and Other Lymphoproliferative Disorders
por: Awan, Haneef, et al.
Publicado: (2010)

A case of lymphoproliferative disorder of NK-cells: aggressive immunophenotype but indolent behavior
por: Shi, Min, et al.
Publicado: (2015)

Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorders with a T- or NK-cell phenotype
por: Satou, Akira, et al.
Publicado: (2019)

Biology and genetics of extranodal mature T-cell and NK-cell lymphomas and lymphoproliferative disorders
por: Lewis, Natasha E., et al.
Publicado: (2023)

Inhibition of glioblastoma malignancy by Lgl1
por: Gont, Alexander, et al.
Publicado: (2014)

Treatment Induced Cytotoxic T-Cell Modulation in Multiple Myeloma Patients
por: Barilà, Gregorio, et al.
Publicado: (2021)

BLNK mutation associated with T-cell LGL leukemia and autoimmune diseases: Case report in hematology
por: Fouquet, Guillemette, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_t8r6dqfu604lbfos30em4d87gi